tiprankstipranks
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
US Market
OLMA
Olema Pharmaceuticals
RESEARCH TOOLSreports

Olema Pharmaceuticals (OLMA) Financial Statements

Compare
957 Followers

Olema Pharmaceuticals Financial Overview

Olema Pharmaceuticals's market cap is currently $1.23B. The company's EPS TTM is $-0.5; its P/E ratio is -13.39; Olema Pharmaceuticals is scheduled to report earnings on March 16, 2026, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -178.70M$ -142.26M$ -104.96M$ -106.99M$ -71.49M
EBITDA$ -178.21M$ -141.87M$ -104.58M$ -106.63M$ -71.33M
Net Income$ -162.45M$ -129.47M$ -96.66M$ -104.79M$ -71.10M
Balance Sheet
Cash & Short-Term Investments$ 505.44M$ 434.09M$ 261.81M$ 204.42M$ 287.25M
Total Assets$ 533.43M$ 450.98M$ 276.94M$ 215.65M$ 295.94M
Total Debt$ 1.19M$ 1.43M$ 2.42M$ 2.56M$ 3.29M
Net Debt$ -47.11M$ -138.05M$ -66.12M$ -21.14M$ -10.52M
Total Liabilities$ 54.87M$ 42.02M$ 23.05M$ 18.10M$ 11.38M
Stockholders' Equity$ 478.56M$ 408.96M$ 253.90M$ 197.55M$ 284.57M
Cash Flow
Free Cash Flow$ -146.72M$ -104.51M$ -83.73M$ -82.43M$ -52.27M
Operating Cash Flow$ -146.72M$ -104.35M$ -83.73M$ -82.06M$ -50.69M
Investing Cash Flow$ -155.76M$ -93.53M$ -4.85M$ 91.48M$ -275.44M
Financing Cash Flow$ 211.30M$ 268.82M$ 133.41M$ 476.00K$ 1.39M
Currency in USD

Olema Pharmaceuticals Earnings and Revenue History

Income Statement >

Olema Pharmaceuticals Debt to Assets

Balance Sheet >

Olema Pharmaceuticals Cash Flow

Cash Flow >

Olema Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >